First in human implantation of a novel transfemoral self-expanding transcatheter heart valve to treat pure aortic regurgitation
The first case of a novel JenaValve design using the transfemoral approach in a 78 year old female patient with pure aortic regurgitation is described in this article.
Aortic stenosis prevalence and balloon aortic valvuloplasty publish
The transformation in the field of interventional cardiology is unprecedented. Since the late 1970's, rapid changes have taken place, and today, interventional cardiology encompasses an ever-growing list of diagnostic and therapeutic percutaneous procedures performed in the cathlab. The field was initially driven by the treatment of the vasculature system, but has expanded over the last 15 years to structural heart disease.
First FIM Percutaneously Implanted Heart Valve (PHV) implantation on 16 April, 2002
On April 16, 2002, at the Charles Nicolle University Hospital in Rouen, France, the Interventional Cardiologist, Professor Alain Cribier performed the first transcatheter aortic valve replacement procedure in the world. He used a Prosthetic valve thrombosis (PVT) percutaneous heart valve.
Alain G. Cribier
Alain Cribier, M.D., FACC, FESC (born in 1945) is a French interventional cardiologist and is a Professor of Medicine and Director of Cardiology at the University of Rouen's Charles Nicolle Hospital, France.As part of celebrating the 15th year of TAVI, we are presenting a summary of Alain Cribier’s career highlights and quests.This page is dedicated to the personal life and accomplishments.
Indirect Educational Sponsorship
The new Code of Ethics regulates interactions between industries, Healthcare Professionals and Healthcare Organisations (ex: learned societies, conference organisers, associations, et al.). It prevents improper perceptions regarding funding support and/or various actions taken by industries in the context of third-party organised events. Concretely:The Code aims at reinforcing the independence of said events by offering an indirect sponsorship scheme to support the invitation of Healthcare ProfessionalsEuropa Group is equipped to receive Educational Allowances from Industry PartnersPractitioners keep their MyPCR account up-to-date to maximise their chances of being selected for an Educational Allowance
MedTech Europe and its other regional counterparts are proactive with this self-regulation in creating a safe environment that protects all stakeholders from inadequate relationships.
The new regulation is coming into force on 1 January 2018.
What is APACMed?
APACMed is the main representative for all key stakeholders surrounding the medical technology industry in Asia Pacific. Its prime objective is to promote the importance of innovation and the value of transparency in every collaborative interaction.
The Code concerns you especially if:you are a physician / nurse / allied professional wishing to join AsiaPCRyou are a physician / nurse / allied professional wishing to join PCR Tokyo Valvesan industry partner willing to support delegate / faculty attendance. Get in touch with us!
As a physician, answer the Call for Application and maximise your chances to be supported !AsiaPCR is around the corner!
Submit your Application
What is MedTech Europe?
A broad modification of the MedTech Europe "Code of Ethical Business Practice" is underway. This change is devised to bring further transparency to the making and handling of third-party organised educational events.
The Code concerns you especially if:you are a physician / nurse / allied professional wishing to join EuroPCR 2018 and/or PCR London Valves 2018an industry partner willing to support delegate / faculty attendance. Get in touch with us!
New regulations, an opportunity for Industry Partners
As a trusted third-party, Europa Group is fully committed to perpetuating long-term collaboration between industry partners and healthcare professionals. We are deeply involved in the matter of Educational Events for cardiovascular specialists and are willing to ensure that, as of 1st January 2018, industry partners can continue to take an active part in supporting practitioners’ attendance to our Courses.
Educational Allowances for practitioners
Interventional cardiology is constantly progressing through innovation and technical modifications. Hence the importance of continuing medical education! How to keep on harnessing PCR Courses to practice and further your skills?
As a major trusted third-party, Europa Group provides you with an extensive Course that makes for an environment of knowledge, learning and fraternity.
Update your My PCR account, broaden your chances of earning Educational Allowances. Get involved by following a few quick and easy steps!
Create/Update your account:
Europa Group, trusted third-party
Europa Group is a Professional Conference Organiser operating on behalf of PCR. It plays as a trusted third-party for more than 50 medical societies. For the past 30 years, the group has actively supported PCR in its multifaceted mission: providing patients with the best possible medical care; handing the cardiovascular community all the necessary resources to share knowledge, experience and practice; organising annual courses be it in Europe, Asia, Africa or the Middle East; publishing textbooks and online courses...
By establishing a virtuous long-term working collaboration with industry partners, Europa Group’s mission is to provide the means to sustain the PCR vision of enhancing HCPs clinical skills for the benefit of the patient.
Visit Europa Group